Cargando…
Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
BACKGROUND: Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19. Despite the ongoing controversies, HCQ was recommended for ma...
Autores principales: | Almazrou, Saja H., Almalki, Ziyad S., Alanazi, Abdullah S., Alqahtani, Abdulhadi M., Alghamd, Saleh M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527306/ https://www.ncbi.nlm.nih.gov/pubmed/33020690 http://dx.doi.org/10.1016/j.jsps.2020.09.019 |
Ejemplares similares
-
Clinical Characteristics and Outcomes Among COVID-19 Hospitalized Patients with Chronic Conditions: A Retrospective Single-Center Study
por: Almalki, Ziyad Saeed, et al.
Publicado: (2020) -
Assessing the Severity of Illness in Patients With Coronavirus Disease in Saudi Arabia: A Retrospective Descriptive Cross-Sectional Study
por: Alqahtani, Abdulhadi M., et al.
Publicado: (2020) -
Impact of COVID-19 on Public Knowledge and Attitudes Toward Participating in Clinical Trials in Saudi Arabia: A Cross-Sectional Study
por: Alqahtani, Abdulhadi M, et al.
Publicado: (2021) -
Assessing Barriers and Facilitators for Implementing Clinical Practice Guidelines in Middle Eastern and North African Region: Delphi Study
por: Almazrou, Saja H., et al.
Publicado: (2023) -
Households’ Direct Economic Burden Associated with Chronic Non-Communicable Diseases in Saudi Arabia
por: Almalki, Ziyad S., et al.
Publicado: (2022)